William J. Link PhD - 05 Jan 2022 Form 4 Insider Report for Oyster Point Pharma, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 05 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jan 2022, 17:08:51 UTC
Prior SEC filing: 23 Dec 2021
Next SEC filing: 08 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Brandon Fenn, Attorney-in-Fact

Key filing fact

William J. Link PhD filed Form 4 for Oyster Point Pharma, Inc. on 07 Jan 2022.

Key facts

This page summarizes William J. Link PhD's Form 4 filing for Oyster Point Pharma, Inc..
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Jan 2022, 17:08.

Change

Previous filing in this sequence was filed on 23 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OYST transaction

Common Stock

Other

Transaction value: $0
Shares: +6,438
Change %: +24%
Price: $0.000000
Shares after: 33,480
Date: 05 Jan 2022
Ownership: By Limited Partnership
Footnotes: F1, F2

OYST transaction

Common Stock

Other

Transaction value: $0
Shares: +401
Change %: +24%
Price: $0.000000
Shares after: 2,074
Date: 05 Jan 2022
Ownership: By Trust
Footnotes: F3, F4

OYST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,942
Date: 05 Jan 2022
Ownership: By LLC
Footnotes: F5

OYST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,066
Date: 05 Jan 2022
Ownership: Direct

OYST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,465
Date: 05 Jan 2022
Ownership: See Footnote
Footnotes: F6

OYST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 414,607
Date: 05 Jan 2022
Ownership: See Footnote
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. ("Capital IV") to Versant Ventures IV, LLC ("Ventures IV"), its sole general partner, without consideration, and from Ventures IV to Link Family Enterprise, LP as a member of Ventures IV.

Footnote F2

Shares held by Link Family Enterprise, LP. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.

Footnote F3

Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. ("Versant Side Fund IV") to The Link Family Trust, dated May 19, 2005, without consideration.

Footnote F4

Shares held by The Link Family Trust. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the Trustee of The Link Family Trust.

Footnote F5

Shares held by Flying L Partners VII, LLC. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Flying L Partners VII, LLC.

Footnote F6

Shares held by Versant Side Fund IV following its distribution to the Reporting Person reported herein and its other members. The Reporting Person may be deemed to beneficially own the shares held by Versant Side Fund IV as a managing member of Ventures IV, its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant Side Fund IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Footnote F7

Shares held by Capital IV following its distribution to the Reporting Person herein and its other members. The Reporting Person may be deemed to beneficially own the shares held by Capital IV as a managing member of Ventures IV, its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Capital IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.